ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
| Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
| Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
| Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
| Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
| Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
| Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
| Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |